Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-30 @ 9:11 AM
Study NCT ID:
NCT05071703
Status:
COMPLETED
Last Update Posted:
2023-10-06
First Post:
2021-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-28
First Submit QC Date:
None
Study First Post Date:
2021-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-04
Last Update Post Date:
2023-10-06
Last Update Post Date Type:
ACTUAL